Since KRAS and BRAF mutations are thought to occur early in colorectal carcinogenesis [5], [6], it seems biologically plausible that exposures such as obesity might modulate CRC risk differentially according to KRAS and BRAF mutation status of the tumours [19], [20]. The gene discussed is BRAF; the disease is obesity due to melanocortin 4 receptor deficiency.